| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |